Dry Eye & Ocular Surface Disease
IPL & RF
Dell et al. 2017
In a prospective clinical study, IPL treatment improved meibomian gland function, tear stability, and dry eye symptoms in patients with evaporative dry eye.
https://pdfs.semanticscholar.org/063b/ec4dc979ecd382a7a3ad314670dd383d1923.pdf
Martínez-Hergueta et al., Asia-Pacific Journal of Ophthalmology, 2023 (IPL perioperative RCT)
In a randomized, triple-masked clinical trial, perioperative IPL therapy significantly improved tear stability, meibomian gland function, and dry eye symptoms after laser refractive surgery compared to controls.
Chelnis et al., Clinical Ophthalmology, 2023 (IPL + RF combination study)
In a prospective clinical study, combination therapy with IPL, radiofrequency, and meibomian gland expression significantly improved meibomian gland function and dry eye symptoms, with greater improvement compared to IPL alone.
Prokera Amniotic Membrane
Cheng et al. Prokera Dry Eye Study
In a prospective clinical study, cryopreserved amniotic membrane (Prokera®) significantly improved signs and symptoms of moderate to severe dry eye disease, promoting rapid ocular surface healing and reducing inflammation.
https://pubmed.ncbi.nlm.nih.gov/26387870/
Myopia Control
Stellest Lens
Bao et al. 2022 Stellest HALT Study
In a 2-year randomized clinical trial of 157 children, spectacle lenses with aspherical lenslets significantly slowed myopia progression and axial elongation compared to single-vision lenses, with greater efficacy seen in higher asphericity designs.
https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2790589
Ortho-Keratology
Cho et al. 2012 ROMIO Study
In a 2-year randomized clinical trial, orthokeratology lenses slowed axial elongation by approximately 43% compared to single-vision spectacles in myopic children.
https://pubmed.ncbi.nlm.nih.gov/22969068/
MiSight Contact Lenses
Chamberlain et al. 2019 – A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control
In a 3-year double-masked, multicenter randomized clinical trial, MiSight® 1-day lenses reduced myopia progression by ~59% and axial elongation by ~52% compared to single-vision lenses in children.”